Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

Simon Fraser University

$25,000.00

Molecular dynamics simulations of Ligand-Enzyme complexes for a novel target involved in cancer metabolism

FY 2012-13

Summary
Cancer is a worldwide health problem and is the leading cause of death in Canada. Novel treatment strategies are constantly being sought. Compared to normal cells, cancer cells exhibit aberrant metabolism characterized by increased glucose uptake and rapid growth. The collaboration between Alectos Therapeutics and the Pinto group at SFU aims to use high-level computer algorithms to model and predict the binding mode of small-molecule inhibitors targeting an enzyme involved in tumour metabolism. This proposed NSERC Engage project will capitalize on the unique molecular modeling capabilities of the Pinto group at SFU to characterize the three-dimensional structure and energetics of inhibitor binding to more fully understand protein-inhibitor interactions on a molecular level. Using a collaborative approach, Alectos and the Pinto group will carry out computational modeling studies on a variety of enzyme inhibitors. The success of this project may lead to a better understanding of inhibitor binding, cellular metabolism, and ultimately a new treatment for cancer.
Program
Engage Grants Program
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
434441-2012
Name nom
Pinto, BrianMario
Department département
Chemistry
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
3705
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Bio-organic chemistry
Research subject fr
Chimie bio-organique
Partie
1
Nb partie
1
Application title
Molecular dynamics simulations of Ligand-Enzyme complexes for a novel target involved in cancer metabolism
Keyword
NSERC
Application summary
Cancer is a worldwide health problem and is the leading cause of death in Canada. Novel treatment strategies are constantly being sought. Compared to normal cells, cancer cells exhibit aberrant metabolism characterized by increased glucose uptake and rapid growth. The collaboration between Alectos Therapeutics and the Pinto group at SFU aims to use high-level computer algorithms to model and predict the binding mode of small-molecule inhibitors targeting an enzyme involved in tumour metabolism. This proposed NSERC Engage project will capitalize on the unique molecular modeling capabilities of the Pinto group at SFU to characterize the three-dimensional structure and energetics of inhibitor binding to more fully understand protein-inhibitor interactions on a molecular level. Using a collaborative approach, Alectos and the Pinto group will carry out computational modeling studies on a variety of enzyme inhibitors. The success of this project may lead to a better understanding of inhibitor binding, cellular metabolism, and ultimately a new treatment for cancer.